Leaving behind a diseased small bowel during surgery for Crohn's disease : Long-term outcomes
© 2023. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd..
PURPOSES: Stricture is a common complication of Crohn's disease (CD) and may be treated with bowel-sparing procedures. Our study analyzed what happens in terms of intestinal and systemic inflammation when the diseased bowel is left behind following surgery.
METHODS: In this retrospective study, we enrolled 42 consecutive patients who underwent strictureplasty (alone or with resection) for stricturing CD. Control patients who underwent complete diseased bowel resection were identified and propensity score-matched for the sex, age, and history of abdominal surgery. Biohumoral values were collected at follow-up examinations at 1, 6, and 12 months after surgery. Magnetic resonance imaging (MRI) was performed before and after strictureplasty in 19 patients.
RESULTS: In the strictureplasty group, fecal calprotectin levels were decreased at 12 months (p = 0.03), whereas in the resectiongroup, they were decreased at 6 months (p = 0.02). On MRI, the ADC [apparent diffusion coefficient] (p < 0.001), wall thickness (p = 0.046) and Magnetic Resonance Index of Activity (MaRIA) (p < 0.001) and Clermont (p < 0.001) scores were improved after strictureplasty. Surgical recurrence was more frequent in the strictureplasty group than in the resection group (p = 0.003).
CONCLUSIONS: Our retrospective study showed that even if the diseased bowel was left behind after surgery, the intestinal inflammatory activity still decreased. However, the permanence of the diseased bowel still increased the risk of reoperation, probably because of the fibrotic nature of the stenosis and the multifocality of CD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
---|---|
Enthalten in: |
Surgery today - (2023) vom: 26. Okt. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Angriman, Imerio [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 26.10.2023 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1007/s00595-023-02759-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363749608 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363749608 | ||
003 | DE-627 | ||
005 | 20231226094017.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00595-023-02759-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1212.xml |
035 | |a (DE-627)NLM363749608 | ||
035 | |a (NLM)37882838 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Angriman, Imerio |e verfasserin |4 aut | |
245 | 1 | 0 | |a Leaving behind a diseased small bowel during surgery for Crohn's disease |b Long-term outcomes |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 26.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2023. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd. | ||
520 | |a PURPOSES: Stricture is a common complication of Crohn's disease (CD) and may be treated with bowel-sparing procedures. Our study analyzed what happens in terms of intestinal and systemic inflammation when the diseased bowel is left behind following surgery | ||
520 | |a METHODS: In this retrospective study, we enrolled 42 consecutive patients who underwent strictureplasty (alone or with resection) for stricturing CD. Control patients who underwent complete diseased bowel resection were identified and propensity score-matched for the sex, age, and history of abdominal surgery. Biohumoral values were collected at follow-up examinations at 1, 6, and 12 months after surgery. Magnetic resonance imaging (MRI) was performed before and after strictureplasty in 19 patients | ||
520 | |a RESULTS: In the strictureplasty group, fecal calprotectin levels were decreased at 12 months (p = 0.03), whereas in the resectiongroup, they were decreased at 6 months (p = 0.02). On MRI, the ADC [apparent diffusion coefficient] (p < 0.001), wall thickness (p = 0.046) and Magnetic Resonance Index of Activity (MaRIA) (p < 0.001) and Clermont (p < 0.001) scores were improved after strictureplasty. Surgical recurrence was more frequent in the strictureplasty group than in the resection group (p = 0.003) | ||
520 | |a CONCLUSIONS: Our retrospective study showed that even if the diseased bowel was left behind after surgery, the intestinal inflammatory activity still decreased. However, the permanence of the diseased bowel still increased the risk of reoperation, probably because of the fibrotic nature of the stenosis and the multifocality of CD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Bowel stenosis | |
650 | 4 | |a Crohn’s disease | |
650 | 4 | |a Strictureplasty | |
700 | 1 | |a Degasperi, Silvia |e verfasserin |4 aut | |
700 | 1 | |a Mescoli, Claudia |e verfasserin |4 aut | |
700 | 1 | |a Lacognata, Carmelo |e verfasserin |4 aut | |
700 | 1 | |a Armellin, Claudia |e verfasserin |4 aut | |
700 | 1 | |a Caruso, Antonino |e verfasserin |4 aut | |
700 | 1 | |a Scognamiglio, Federico |e verfasserin |4 aut | |
700 | 1 | |a Fassan, Matteo |e verfasserin |4 aut | |
700 | 1 | |a D'Incà, Renata |e verfasserin |4 aut | |
700 | 1 | |a Savarino, Edoardo |e verfasserin |4 aut | |
700 | 1 | |a Zingone, Fabiana |e verfasserin |4 aut | |
700 | 1 | |a Spolverato, Gaya |e verfasserin |4 aut | |
700 | 1 | |a Pucciarelli, Salvatore |e verfasserin |4 aut | |
700 | 1 | |a Bardini, Romeo |e verfasserin |4 aut | |
700 | 1 | |a Ruffolo, Cesare |e verfasserin |4 aut | |
700 | 1 | |a Scarpa, Marco |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Surgery today |d 1997 |g (2023) vom: 26. Okt. |w (DE-627)NLM012623938 |x 1436-2813 |7 nnns |
773 | 1 | 8 | |g year:2023 |g day:26 |g month:10 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00595-023-02759-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2023 |b 26 |c 10 |